MHC-I in the hippocampus promotes comorbid depressive symptoms in bone cancer pain via the upregulation of microglial TREM2/DAP12 signaling
- 2 January 2024
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 461, 114843
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer PatientsCancer Nursing, 2012
- Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancerGut, 2010
- Modulation of Thalamic Nociceptive Processing after Spinal Cord Injury through Remote Activation of Thalamic Microglia by Cysteine–Cysteine Chemokine Ligand 21The Journal of Neuroscience, 2007
- Exploring the Relationships Between Depression, Hopelessness, Cognitive Status, Pain, and Spirituality in Patients With Advanced CancerArchives of Psychiatric Nursing, 2007
- Antinociceptive effect of intra-hippocampal CA1 and dentate gyrus injection of MK801 and AP5 in the formalin test in adult male ratsEuropean Journal of Pharmacology, 2007
- Nociceptive processing in the human brainCurrent Opinion in Neurobiology, 2005
- Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNSNeurobiology of Disease, 2005
- Expression of Major Histocompatibility Complex class l Molecules on the Different Cell Types in Multiple Sclerosis LesionsBrain Pathology, 2004
- Microglia in the rat neurohypophysis increase expression of class I major histocompatibility antigens following central nervous system injuryJournal of Neuroimmunology, 1994
- Inducible expression of H–2 and Ia antigens on brain cellsNature, 1984